Cite
HARVARD Citation
Yazici, Y. et al. (n.d.). SAT0175 A descriptive analysis of real-world treatment patterns in a turkish rheumatology population that continued innovator infliximab (REMICADE) therapy or switched to biosimilar infliximab. Annals of the rheumatic diseases. p. 836. [Online].